BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23763409)

  • 1. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.
    Flagg EW; Schwartz R; Weinstock H
    Am J Public Health; 2013 Aug; 103(8):1428-35. PubMed ID: 23763409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014.
    Flagg EW; Torrone EA
    Am J Public Health; 2018 Jan; 108(1):112-119. PubMed ID: 29161070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
    Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
    Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M; Mesher D; Mohammed H; Soldan K
    Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States.
    Hariri S; Schuler MS; Naleway AL; Daley MF; Weinmann S; Crane B; Newcomer SR; Tolsma D; Markowitz LE
    Am J Epidemiol; 2018 Feb; 187(2):298-305. PubMed ID: 28641366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.
    Mikolajczyk RT; Kraut AA; Horn J; Schulze-Rath R; Garbe E
    Sex Transm Dis; 2013 Jan; 40(1):28-31. PubMed ID: 23250300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
    Shing JZ; Hull PC; Zhu Y; Gargano JW; Markowitz LE; Cleveland AA; Pemmaraju M; Park IU; Whitney E; Mitchel EF; Griffin MR
    Papillomavirus Res; 2019 Jun; 7():141-149. PubMed ID: 30980966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K; Horn J; Mikolajczyk R
    BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
    Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
    BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States.
    Yakely AE; Avni-Singer L; Oliveira CR; Niccolai LM
    Sex Transm Dis; 2019 Apr; 46(4):213-220. PubMed ID: 30461595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
    Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
    J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asian guidelines for condyloma acuminatum.
    Sindhuja T; Bhari N; Gupta S
    J Infect Chemother; 2022 Jul; 28(7):845-852. PubMed ID: 35341674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
    Sandø N; Kofoed K; Zachariae C; Fouchard J
    Acta Derm Venereol; 2014 May; 94(3):288-92. PubMed ID: 24150529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why are anogenital warts diagnoses decreasing in the U.K.: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?
    Clarke E; Board C; Patel N; Atkinson L; Tulloch H; Patel R
    Sex Transm Infect; 2014 Dec; 90(8):587. PubMed ID: 25398729
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
    Perkins RB; Lin M; Wallington SF; Hanchate A
    Sex Transm Dis; 2017 Jun; 44(6):365-370. PubMed ID: 28499288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.